Studies have shown that NEDD4L inhibits esophageal squamous cell carcinoma by inducing MYC ubiquitination and decreasing SLC1A5 expression (Cheng W. et al., 2022). This evidence concerns the gene SLC1A5 and esophageal squamous cell carcinoma.